YOLFTbeta
64

Ttbio Corp.

6493 · TWO · Healthcare / Medical Instruments & Supplies

29.05TWD+0.00 (0.00%)

Price History

Full chart

Market Stats

Previous Close29.05
Open29.05
Day Range28.50 – 29.40
52-Week Range21.00 – 60.20
Volume7.35K
Market Cap1.08B
P/E (TTM)0.00
Forward P/E0.00
EPS-0.47
Dividend Yield0.00%
Beta0.58
50-Day Avg38.37
200-Day Avg31.89

About

Ttbio Corp. manufactures, sells, and maintains medical devices under the TTBIO brand name in Taiwan and the United States. The company provides high and low-speed hand piece products, dental spare parts, service rotors, maintenance units, electric hand piece systems, and precision-machined components. It serves various industries, including medical, automotive, aerospace, security, computer components, maintenance parts, and custom machining. Ttbio Corp. was founded in 2012 and is based in Taichung, Taiwan.

Company Details

  • SectorHealthcare
  • IndustryMedical Instruments & Supplies
  • CEOSheng Jie Su
  • Employees138
  • HeadquartersNo. 07, 6th Road Industry Park, Taichung, Taiwan, 40755, Taiwan
  • Websitehttps://www.ttbio.com

Leadership

  • Sheng Jie SuGM & Director
  • Shu Rong YangAssistant Manager of Finance Department
  • Ruhui ZhangAccounting Supervisor
  • Yao Qing CaiManager of Business Department

Financials

Income Statement

Currency: TWD2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue267.09M178.96M305.52M418.88M318.09M312.12M398.88M
Growth (%)--33.00%+70.72%+37.11%-24.06%-1.88%+27.80%
Cost of Revenue190.34M130.07M215.07M296.35M239.67M239.34M328.54M
Gross Profit76.75M48.89M90.45M122.53M78.42M72.77M70.34M
Gross Margin28.74%27.32%29.61%29.25%24.65%23.32%17.63%
Operating Expense52.28M62.61M78.19M84.17M79.28M75.06M91.12M
Operating Income24.46M-13.72M12.26M38.36M-862.00K-2.29M-20.79M
Operating Margin9.16%-7.67%4.01%9.16%-0.27%-0.73%-5.21%
EBITDA63.69M84.35M52.58M89.29M52.11M47.19M20.36M
EBITDA Margin23.85%47.14%17.21%21.32%16.38%15.12%5.11%
Net Income37.99M45.88M11.53M39.80M6.68M2.59M-21.30M
Net Income Margin14.22%25.64%3.77%9.50%2.10%0.83%-5.34%
R&D20.23M20.23M26.06M30.68M25.36M23.82M22.40M
R&D as % of Total Revenue7.57%11.30%8.53%7.32%7.97%7.63%5.61%
Interest Expense2.01M1.57M1.18M1.58M2.30M4.93M5.45M
Interest Expense % of Total Revenue0.75%0.88%0.39%0.38%0.72%1.58%1.37%

Balance Sheet

Currency: TWD2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets469.87M409.71M464.73M526.72M511.86M608.29M622.44M
Total Liabilities148.00M124.45M169.26M203.61M212.17M313.18M265.06M
Total Equity321.87M285.26M295.47M323.11M299.69M295.11M357.38M
Cash80.21M42.14M70.10M113.05M59.36M82.60M53.75M
Total Debt87.67M77.82M75.91M125.75M144.61M212.43M-
Net Debt7.46M35.68M5.81M12.71M85.25M129.84M57.97M

Cash Flow

Currency: TWD2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow73.61M-3.19M47.13M50.11M4.00M25.35M-41.01M
Investing Cash Flow-27.69M59.00M-16.30M-43.67M-48.34M-10.91M-
Financing Cash Flow-39.62M-93.88M-2.87M36.51M-9.34M8.79M-
Capital Expenditure30.09M17.63M16.65M41.30M43.24M8.85M9.00M
Free Cash Flow43.52M-20.82M30.47M8.81M-39.24M16.51M-50.01M
Dividends Paid36.08M84.17M-12.03M30.06M7.21M6.01M
FCF to OCF59.12%652.74%64.66%17.59%-982.35%65.11%121.94%
Dividend Paid to FCF82.90%-404.38%-136.42%-76.60%43.71%-12.02%

Key Statistics & Ratios

Market Cap1.08B
Enterprise Value1.24B
Trailing P/E0.00
Forward P/E0.00
Price / Sales2.48
Price / Book3.00
EPS-0.47
Book Value12.02
Revenue (TTM)433.42M
Gross Profit (TTM)72.98M
EBITDA3.25M
Profit Margin-3.39%
Operating Margin0.37%
Return on Equity-4.53%
Return on Assets-2.15%
Shares Outstanding30.05M
Shares Float6.06M
Beta0.58
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%